基本信息
浏览量:140
职业迁徙
个人简介
As director of the USC Institute for Biomedical Therapeutics, Dr. Humayun and his team are leading the investigation and development of novel neural platforms to diagnose and treat patients with debilitating neurological conditions. Major research applications include developing the next generation of Argus II, the world’s first FDA approved artificial retinal prosthesis for patients suffering from an inherited form of retinitis pigmentosa (RP). As principal investigators, Drs. Humayun and David Hinton, received $19 M funding from CIRM (California Institute for Regenerative Medicine) to lead a stem cell initiative. The research team has developed a unique procedure by which a scaffold of stem-cell derived retinal pigment epithelium cells may be surgically implanted into the back of the eye, replacing diseased tissue to treat those suffering from Age-related Macular Degeneration (AMD).
Mark Humayun, MD, PhD, is the Cornelius J. Pings Chair in Biomedical Sciences, Professor of Ophthalmology, Biomedical Engineering and Cell and Neurobiology, Director of the USC Institute for Biomedical Therapeutics, and Co-Director of the USC Roski Eye Institute. As the director of USC IBT, Dr. Humayun’s vision is to create an interdisciplinary environment of research and discovery. He was elected to the prestigious National Academy of Medicine (NAM) and National Academy of Engineering (NAE) for his pioneering work to restore sight. In addition, amongst the many other awards and recognitions, Dr. Humayun was named Inventor of the Year by R&D magazine (2005) and top 1 % of ophthalmologists in U.S. News & World Report.
Mark Humayun, MD, PhD, is the Cornelius J. Pings Chair in Biomedical Sciences, Professor of Ophthalmology, Biomedical Engineering and Cell and Neurobiology, Director of the USC Institute for Biomedical Therapeutics, and Co-Director of the USC Roski Eye Institute. As the director of USC IBT, Dr. Humayun’s vision is to create an interdisciplinary environment of research and discovery. He was elected to the prestigious National Academy of Medicine (NAM) and National Academy of Engineering (NAE) for his pioneering work to restore sight. In addition, amongst the many other awards and recognitions, Dr. Humayun was named Inventor of the Year by R&D magazine (2005) and top 1 % of ophthalmologists in U.S. News & World Report.
研究兴趣
论文共 732 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Kabir Ahluwalia,Zhaodong Du, Juan Carlos Martinez-Camarillo, Aditya Naik,Biju B Thomas,Dimitrios Pollalis,Sun Young Lee,Priyal Dave,Eugene Zhou,Zeyang Li, Catherine Chester,Mark S Humayun,
International journal of molecular sciencesno. 7 (2024): 3749
Dimitrios Pollalis, Alejandra Gonzalez Calle,Juancarlos Martinez-Camarillo,Kabir Ahluwalia,Cassidy Hinman,Debbie Mitra,Jane Lebkowski,Sun Young Lee,Biju B. Thomas, Faizah Ahmed, Victoria Chan,Jason A. Junge,
EXPERIMENTAL EYE RESEARCH (2024): 109789-109789
Transport in Porous Mediano. 3 (2024): 533-558
Journal of Clinical and Translational Scienceno. s1 (2024): 113-113
IEEE TRANSACTIONS ON ULTRASONICS FERROELECTRICS AND FREQUENCY CONTROLno. 11 (2023): 1527-1535
Current opinion in ophthalmology (2023)
引用0浏览0WOS引用
0
0
Chen Gong,Runze Li,Gengxi Lu,Jie Ji,Yushun Zeng, Jiawen Chen, Chifeng Chang,Junhang Zhang, Lily Xia,Deepthi S Rajendran Nair,Biju B Thomas,Brian J Song,
引用1浏览0WOS引用
1
0
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn